Green Thumb Industries (OTC:GTBIF – Get Free Report) and Yield10 Bioscience (NASDAQ:YTEN – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability and valuation.
Insider & Institutional Ownership
0.1% of Green Thumb Industries shares are owned by institutional investors. Comparatively, 4.9% of Yield10 Bioscience shares are owned by institutional investors. 9.4% of Green Thumb Industries shares are owned by company insiders. Comparatively, 6.1% of Yield10 Bioscience shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Profitability
This table compares Green Thumb Industries and Yield10 Bioscience’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Green Thumb Industries | 5.68% | 3.65% | 2.52% |
| Yield10 Bioscience | N/A | N/A | -296.08% |
Earnings and Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Green Thumb Industries | $1.05 billion | 1.00 | $36.27 million | $0.21 | 23.71 |
| Yield10 Bioscience | $60,000.00 | 0.18 | -$14.45 million | ($26.12) | 0.00 |
Green Thumb Industries has higher revenue and earnings than Yield10 Bioscience. Yield10 Bioscience is trading at a lower price-to-earnings ratio than Green Thumb Industries, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a breakdown of recent ratings and price targets for Green Thumb Industries and Yield10 Bioscience, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Green Thumb Industries | 0 | 0 | 0 | 3 | 4.00 |
| Yield10 Bioscience | 0 | 0 | 0 | 0 | 0.00 |
Risk & Volatility
Green Thumb Industries has a beta of 1.17, indicating that its stock price is 17% more volatile than the S&P 500. Comparatively, Yield10 Bioscience has a beta of 1.48, indicating that its stock price is 48% more volatile than the S&P 500.
Summary
Green Thumb Industries beats Yield10 Bioscience on 11 of the 13 factors compared between the two stocks.
About Green Thumb Industries
Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RHYTHM brands. It distributes its products primarily to third-party retail customers and sells finished products directly to consumers in its own retail stores, as well as direct-to consumer delivery channel. Green Thumb Industries Inc. was founded in 2014 and is headquartered in Chicago, Illinois.
About Yield10 Bioscience
Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts.
Receive News & Ratings for Green Thumb Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Green Thumb Industries and related companies with MarketBeat.com's FREE daily email newsletter.
